The green light of the Ema, the European Medicines Agency, to the Pfizer vaccine for children between 12 and 15 years is behind the corner. From June they too will be able to contribute to mass protection, as has been happening for a few weeks in the United States thanks to the green light of the FDA. For the further step, that of vaccination for the little ones, between 6 months and 11 years – in reality the trials are proceeding for further sub-categories, between 6 months and 5 years and between 5 and 11 – it will take a little longer: the US giant explained that the date could be theearly 2022.
By the end of the year, the results of the Comirnaty experiment will be available (this is the commercial name of the product developed with the German Biontech) between 6 months and 11 years: “If safety and immunogenicity are confirmed – explains the company – we hope to receive authorization for the vaccination of these youngest children by the beginning of 2022 ”. We talked about it here.
In the meantime, we will start with older sisters and brothers, going to protect one of the groups that in recent months has seen the infection rates rise more – albeit without significant clinical consequences in the vast majority of cases. Roberto Speranza, Minister of Health, explained to the Chamber how to vaccinate young people is “strategic and essential for the safe reopening of the next school year“. The goal, in short, is to take advantage of the summer to hit the next school year’s appointment, after the last two decimated by the blocks and resumptions imposed by the pandemic. In the meantime, in Lazio, three days of vaccination are planned dedicated to the graduates.
In the last few hours, however, a very important debate on vaccination for young people in industrialized countries. Andrew Pollard, director of the Oxford Vaccine Group and one of the coordinators of the Astrazeneca vaccine tests, said in fact that “vaccinating the young before the poor is morally wrong“. The expert explained how, while in developing countries the high-risk bands have not yet been vaccinated, or have been covered in a minimal percentage, other countries have already started with the 12-year-olds: “The ultimate goal of a global vaccination program in a pandemic is make sure people don’t die. I have worked in Nepal and Bangladesh, and colleagues there are facing terrible situations. It seems to me completely morally wrong that this could happen at a time when many countries are vaccinating ever younger populations whose risk is very very low. Children have a very close to zero risk of serious illness or death ”.
Albert Bourla, president and CEO of Pfizer, also touched on the topic of the possible third dose, for which studies have already started in Great Britain: “Continuous vaccination beyond 2021 is essential since Covid-19 continues to spread rapidly throughout Europe and the world. We are working to understand if, similar to seasonal flu, annual vaccination can provide the most lasting protection ».
Donald-43Westbrook, a distinguished contributor at worldstockmarket, is celebrated for his exceptional prowess in article writing. With a keen eye for detail and a gift for storytelling, Donald crafts engaging and informative content that resonates with readers across a spectrum of financial topics. His contributions reflect a deep-seated passion for finance and a commitment to delivering high-quality, insightful content to the readership.
